Browse Category

Dividends News 14 December 2025 - 15 December 2025

OCBC Stock (SGX: O39) Today: Share Price Near S$19.2 as Dividends, Buybacks and Wealth Growth Drive 2026 Debate

OCBC Stock (SGX: O39) Today: Share Price Near S$19.2 as Dividends, Buybacks and Wealth Growth Drive 2026 Debate

SINGAPORE (Dec. 15, 2025) — Oversea-Chinese Banking Corporation Limited (OCBC) stock is trading around S$19.2 in mid-afternoon Singapore time on Monday, keeping the lender’s shares close to the record-setting run seen since early November. SG Investors+1 That “near-highs” backdrop matters
Merck stock (MRK): News, dividend date, Keytruda updates and analyst forecasts to watch before the U.S. market opens Dec. 15, 2025

Merck stock (MRK): News, dividend date, Keytruda updates and analyst forecasts to watch before the U.S. market opens Dec. 15, 2025

Merck & Co., Inc. (NYSE: MRK) heads into Monday’s U.S. session (December 15, 2025) with investors juggling a mix of near-term headlines and long-term franchise questions: a fresh dividend “reset” that makes Dec. 15 an important calendar day, ongoing scrutiny
14 December 2025
Amphenol (APH) Stock News, Forecasts and Analysis for Dec. 14, 2025: AI Data-Center Demand, Dividend Catalyst, and Wall Street Targets

Amphenol (APH) Stock News, Forecasts and Analysis for Dec. 14, 2025: AI Data-Center Demand, Dividend Catalyst, and Wall Street Targets

Amphenol (NYSE: APH) stock slid sharply on Friday amid an AI-linked selloff. Here’s what’s new on Dec. 14, 2025—filings, forecasts, analyst targets, dividend dates, and catalysts. Published: December 14, 2025 Amphenol Corporation (NYSE: APH) is back in the spotlight this
Mastercard Stock (NYSE: MA) News Today: $14B Buyback, Dividend Hike, Analyst Targets, and Key Risks (Dec. 14, 2025)

Mastercard Stock (NYSE: MA) News Today: $14B Buyback, Dividend Hike, Analyst Targets, and Key Risks (Dec. 14, 2025)

Updated: December 14, 2025 Mastercard Incorporated (NYSE: MA) is heading into the final stretch of 2025 with fresh momentum from a major shareholder-return announcement—a new $14 billion share repurchase authorization and a 14% dividend increase—while investors continue to weigh the
14 December 2025
Pfizer Stock (PFE) Outlook: This Week’s Key Headlines, Dividend Update, and What to Watch Ahead of 2026 Guidance (Updated Dec. 14, 2025)

Pfizer Stock (PFE) Outlook: This Week’s Key Headlines, Dividend Update, and What to Watch Ahead of 2026 Guidance (Updated Dec. 14, 2025)

Pfizer Inc. (NYSE: PFE) heads into the new trading week with investors balancing two very different storylines: a steady, high-yield “value pharma” profile versus a news-driven catalyst tape around obesity deals, oncology data, cost cuts, and shifting U.S. COVID-vaccine policy.
14 December 2025
1 2 3 4 5 6 31
Go toTop